(Q72827553)
Statements
Temporal and individual variations in the dose of glucocorticoid used for the treatment of salt-losing congenital virilizing adrenal hyperplasia due to 21-hydroxylase deficiency (English)
Sandrini R
56-60; discussion 61
scientific article published on 01 March 1993